SB 444 repeals an exemption that previously allowed intermediate care facilities offering substance use disorder treatment to change bed capacity without a certificate of need. It creates a new exemption for facilities providing *medically managed residential substance use disorder treatment services*, removing the requirement for a certificate of need if they submit 45 days' written notice to the Commission and the Commission determines the change aligns with the state health plan, improves service efficiency, and serves the public interest. This bill directly affects intermediate care facilities focused on substance use disorder treatment by reducing regulatory barriers for expanding bed capacity or establishing new facilities. The key mechanism is replacing a certificate of need with a streamlined notice-and-review process administered by the Commission. (SB 444, "Certificate of Need - Intermediate Health Care Facilities," 2026)
HB 1445, the "Maryland Protecting People With Disabilities Act," changes eligibility rules for home- and community-based services under Maryland's Medicaid program (Maryland Medical Assistance Program). It requires the state to continue services uninterrupted during appeals if an individual loses eligibility, prohibits automatic termination solely due to administrative errors (procedural disenrollment), and mandates data sharing between providers and the Department of Health. The bill directly affects people receiving Developmental Disabilities Administration services and Medicaid beneficiaries who risk losing community-based care due to eligibility disputes. Key provisions include extending appeal timelines (replacing 90-day deadlines with continuous service until appeal resolution) and requiring the state to reserve waiver slots for those who lost eligibility unfairly. These changes aim to align with the Olmstead v. L.C. Supreme Court ruling protecting community integration rights.
HB 1117 requires Maryland's Medicaid program (Maryland Medical Assistance Program) and certain insurers to cover approved "elopement response devices" for specific individuals. These devices - such as door sensors, wearable location trackers, or alert systems - prevent people with cognitive, developmental, or neurological conditions from wandering unsafely (e.g., leaving a supervised area without the ability to return safely). Coverage is mandated when ordered by a qualified healthcare provider and documented in a qualifying plan (like an individualized education plan or dementia care plan) for eligible recipients: those under 21 with early screening eligibility, on home-based waiver programs, or diagnosed with Alzheimer’s/dementia. The bill defines these devices as medical equipment or assistive technology under state programs, ensuring coverage without regard to when the program was established.
HB 1292 requires child advocacy centers in Maryland to ensure all health care professionals providing medical or mental health services are properly licensed or certified and work within their scope of practice. It mandates that centers establish a "continuity of care plan" to notify families when providers change, including contact information for both new and former providers, and allows former providers to assist with care transitions per professional standards. Centers must report specific violations to health occupations boards or the Governor’s Office of Crime Prevention and Policy, and the Governor’s Office must publish annual data about child advocacy centers online. This bill directly affects child advocacy centers, their health care staff, and the children and families receiving services at these centers.
This bill requires Maryland counties with volunteer fire companies to provide no-cost preventive cancer screenings to volunteer firefighters, as defined by the bill. Volunteer fire companies must maintain and annually submit a list of their volunteer firefighters to the county, which must then keep this list on file. Counties can meet this requirement by either offering a free annual health exam including cancer screenings or applying for a specific grant to fund advanced screening technologies like multi-cancer blood tests. The law applies to all counties with volunteer fire companies and takes effect July 1, 2026.
HB 417 (Public Health - Medetomidine and Xylazine Consumer Protection Act) regulates the sale of veterinary drugs medetomidine and xylazine. It prohibits retailers from selling these products without proof the buyer intends to use them for veterinary, scientific, or institutional purposes, and bans sales to anyone under 21. Retailers must maintain records of sales, including age verification and proof of intended use. Violations carry civil fines up to $6,500 per offense, with penalties deposited into Maryland's Substance Abuse Fund. The bill directly affects pharmacies, veterinary suppliers, and online retailers selling these specific products.
HB 633 requires Maryland health insurers, nonprofit health plans, and health maintenance organizations to cover salpingectomy (surgical removal of fallopian tubes) as a preventive measure for ovarian cancer. It prohibits these insurers from charging copayments, coinsurance, or deductibles for this specific procedure, ensuring no out-of-pocket costs for covered individuals. The exception applies only to high-deductible health plans under federal law, allowing the deductible to apply to the procedure in those cases. This law directly affects women eligible for preventive care and the health insurance providers operating in Maryland.
SB 489 modifies Maryland's licensing rules for physicians trained at international medical schools. It exempts applicants who provide evidence of completing two years of postgraduate training accredited by ACGME-I or another board-recognized body from standard educational requirements. These physicians would be permitted to practice medicine only during their initial license term under mandatory supervision, as specified by the Board. The bill takes effect October 1, 2026, directly affecting international medical graduates meeting these specific training criteria.
HB 1167 requires Maryland's Department of Health to replace its outdated Medicaid computer system with a modern, flexible system by 2028. The new system must maintain all current Medicaid functions - including processing medical/dental/pharmacy claims, provider enrollment, and beneficiary inquiries - while meeting federal security and performance standards. The bill mandates integration with existing Medicaid systems by January 2027 and full replacement of the old system by January 2028, subject to federal approval. This change directly affects Medicaid beneficiaries and healthcare providers through more reliable service delivery.
SB 515 requires Maryland's Health Services Cost Review Commission to consider all operational costs incurred by health facilities - including expenses for physicians and other providers without corresponding billing revenue - when setting hospital rates. This affects hospitals and health facilities operating under Maryland's all-payer model, as the Commission must now factor in full costs during rate reviews. The bill amends existing law to mandate that the Commission evaluate facility financial health and certify rates based on complete cost accounting, rather than excluding certain expenses. This change ensures rates more accurately reflect actual facility operations, including costs for professional services that previously weren't fully counted.